1. Merck&Co. (USA) • Revenue $64.17 billion • Core products: PD-1 inhibitor Keytruda (2024 sales of $29.5 billion), HPV vaccine…
Thanks to synthetic biotechnology such as genetic engineering, recombinant collagen has shown great potential in fields such as medicine, beauty,…
1、 The goal of the pilot platform 1. Validation of amplification process: Verify small-scale process parameters (such as temperature, pH,…
